HALE DAVID F 13D/13G Filings for Dermata Therapeutics, Inc. (DRMA)

HALE DAVID F 13D and 13G filings for Dermata Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-08-27
5:02 pm
Purchase
2021-08-17 13D Dermata Therapeutics, Inc.
DRMA
HALE DAVID F 2,597
7.500%
2,597increase
(New Position)
Filing